YBS Biographer Newsletter
Autumn/Winter 2012 Join our mailing list and download the latest and previous copies of our quarterly newsletter.
> Latest Edition

Latest News

Show/Hide Search


Page 1 of 2:  < Prev|1|2|Next >

Date Posted: 03 October 2016
We are pleased to announce that YBS underwent another successful routine GLP/GCP compliance inspection by the MHRA of our facilities in York on 15-16 September 2016.   Read More ...

Date Posted: 01 June 2016
As part of Unilabs York Bioanalytical Solutions’ (Unilabs YBS) commitment to providing an unparalleled service to its clients, YBS is pleased to announce a significant expansion of its Metabolism and Discovery Services facility based at Discovery Park in Sandwich Kent.    Read More ...

Date Posted: 01 May 2014
We are pleased to announce that YBS underwent a successful routine GLP/GCP compliance inspection by the MHRA of our facilities in York on 24-25 April 2014.    Read More ...

Date Posted: 25 March 2013
PRESS RELEASE   Read More ...

Date Posted: 21 March 2012
PRESS RELEASE   Read More ...

Date Posted: 08 November 2011
Dr Tim Leunig explores the ramifications of Pfizer shutting its operations in Kent, and examines the choices on hand for locals.   Read More ...

Date Posted: 19 October 2011
As part of Unilabs York Bioanalytical Solutions’ (Unilabs YBS) commitment to providing an unparalleled service to its clients, YBS is pleased to announce the opening of a new facility on the Discovery Park in Sandwich Kent. The new facility will offer discovery bioanalysis and biotransformation services.    Read More ...

Date Posted: 28 June 2011
Unilabs has been selected by Biogen Idec to provide a companion diagnostic anti-JCV antibody assay test, called STRATIFY-JCV. The test is a highly sensitive two-step ELISA assay used to detect anti-JCV antibodies. The presence of anti-JCV antibodies is one in a three-factor risk stratification algorithm, along with prior immunosuppressant use and treatment duration, used to calculate the risk of TYSABRI-treated patients developing progressive multifocal leukoencephalopathy (PML).   Read More ...

Date Posted: 19 April 2011
Unilabs York Bioanalytical Solutions (YBS) has a history of employing cutting edge technology to maintain its place as Europe’s premier, independent bioanalytical facility.   Read More ...

Date Posted: 01 December 2010
Method Development specialist brings more than 20 years of experience within the drug development industry to ensure that Unilabs YBS is positioned as one of the most significant independent suppliers of bioanalysis for NCEs and NBEs as well as biomarkers and sample management in Europe.   Read More ...

Page 1 of 2:  < Prev|1|2|Next >
Printer Friendly  |   Sitemap © Unilabs Bioanalytical Solutions 2010 - 2017  |   Privacy Policy  |   Website Disclaimer  |   Website Credits